ClinicalTrials.Veeva

Menu

Shaping Motor Neural Functioning of Developmental Stuttering to Improve Fluency

I

IRCCS San Camillo, Venezia, Italy

Status

Completed

Conditions

Stuttering

Treatments

Device: transcranial Electrical Stimulation
Behavioral: Speech Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05306782
GR-2018-12366027

Details and patient eligibility

About

Developmental stuttering (DS) is a motor/speech disorder, characterized by specific alterations in the functioning of brain circuits. Non-invasive brain stimulation may be useful to shape the altered functioning and connectivity of these systems. As a consequence, this project aims to expand the neurophysiological understanding of DS, evaluating effects of transcranial electrical stimulation (tES) on speech fluency and brain functioning of adults with persistent DS. This project will provide high-impact insights into the functioning of DS neural system, also proposing innovative and/or personalized rehabilitation.

Full description

Investigators will evaluate the effect of different tES protocols targeting motor associative regions (about 10 "consecutive" stimulation sessions, in different days; tES will be compared to sham stimulation), in association with "canonical" speech therapy. About 30 right-handed adults with idiopathic and persistent DS since childhood will be recruited (age 18-59 years; please see below for inlusion/exclusion criteria). Participants will be subdivided in three groups (in association to speech therapy): two groups will undergo transcranial random noise stimulation or transcranial direct current stimulation, while the third group will undergo sham (placebo) stimulation . Effects will be assessed by measuring stuttering severity (i.e. objective evaluation of stuttering), behavioral/cognitive scales (i.e. subjective evaluation of stuttering), as well as a series of neurophysiological indexes useful to evaluate brain functioning and connectivity (e.g. TMS[transcranial magnetic stimulation]-induced motor/evoked potentials and EEG brain activity). Evaluations will be realized before the start of the tES protocols, as well as at the end of the cycles. Follow-up evaluations (starting from about 6 weeks after completion of stimulation sessions) are also foreseen after the end of the treatments.

Enrollment

24 patients

Sex

All

Ages

18 to 59 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

(main) Inclusion Criteria:

-Right-handed adults with idiopathic, persistent DS since childhood

(main) Exclusion Criteria:

  • Contraindications to non-invasive brain stimulation;
  • Currently assumption of drugs acting on the Central Nervous System;
  • Presence of overt neurological/psychiatric/medical conditions or overt comorbidities (e.g. obsessive-compulsive disorder).

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Triple Blind

24 participants in 3 patient groups

Transcranial Random Noise Stimulation
Experimental group
Description:
Transcranial Random Noise Stimulation (1.5 mA, High Frequency) administered by using surface scalp electrodes (20 minutes, initial part of the session) in correspondence of associative motor regions, during speech therapy sessions (45 minutes).
Treatment:
Behavioral: Speech Therapy
Device: transcranial Electrical Stimulation
Transcranial Direct Current Stimulation
Experimental group
Description:
Transcranial Direct Current Stimulation (1.5 mA, anodal) administered by using surface scalp electrodes (20 minutes, initial part of the session) in correspondence of associative motor regions, during speech therapy sessions (45 minutes).
Treatment:
Behavioral: Speech Therapy
Device: transcranial Electrical Stimulation
Sham Direct Current/Random Noise Stimulation
Sham Comparator group
Description:
Sham stimulation administered by using surface scalp electrodes (20 minutes, initial part of the session) in correspondence of associative motor regions, during speech therapy sessions (45 minutes).
Treatment:
Behavioral: Speech Therapy
Device: transcranial Electrical Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Pierpaolo Busan, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems